A partnership making R2R workflow (“Reagent to Report”) a reality by combining Biocare’s automated IHC instrumentation and reagents with ASI’s computer-aided imaging and analysis
Carlsbad, California and Concord, California, December 4, 2013 – Applied Spectral Imaging Inc. (ASI) and Biocare Medical, LLC (Biocare) announced today the signing of a strategic partnership agreement in which Biocare [...]
Biocare Medical would like to thank you for making the 39th Annual National Society of Histotechnology Providence, Rhode Island a great success! Hundreds had a chance to embark on our Voyage Royale, braving the high seas to play nautical-themed games and disembarked with a Biocare Histocrew T-shirt.
Thank you for making the show such a great [...]
Concord, CA, June 10, 2013 – Biocare Medical is proud to announce the availability of a new line of Supernova antibodies. Supernovas contain a higher antibody concentration than standard predilutes, providing versatility to a client’s current test menu. At Biocare, we aim to enable the client to consider all options and determine the most optimal [...]Read more
Concord, CA, May 14, 2013 – Biocare Medical is proud to announce the availability of a new Uroplakin II mouse monoclonal antibody (IVD). Studies have shown UP II mRNA to be expressed in both bladder cancer tissues and peripheral blood of patients with primary and metastatic urothelial carcinoma.
Urothelial carcinoma (UC) of the bladder typically originates [...]
Enhancing the VP Echelon product line, Biocare is pleased to announce the addition of p40 mouse monoclonal, Arginase-1, and Uroplakin II to our menu of prediluted antibodies optimized for the Ventana® BenchMark® XT Immunohistochemistry Staining Systems.
The mouse monoclonal antibody p40 [BC28] may have applications in cases where p63 is used. While p63 has proven to [...]
Biocare Medical would like to thank you for making the 102nd Annual United States and Canadian Academy of Pathology in Baltimore, MD a great success! Many attendees took advantage of a great opportunity to learn more about our IHC products from antibodies to instrumentation.
Biocare was proud to be involved in four poster presentations, highlighting some [...]
Biocare Medical is proud to announce the availability of a new highly specific p40 mouse monoclonal antibody (IVD). Mouse monoclonal anti-p40 [BC28] demonstrated similar sensitivity and specificity as the rabbit polyclonal p40, staining 97% (65/67) of cases of lung squamous cell carcinoma (SqCC) and 0% (0/71) cases of lung adenocarcinoma (ADC), in an in-house study. [...]Read more
Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group and Biocare Medical, LLC (Biocare) today announced that they have entered into a non-exclusive license agreement to allow Biocare access to certain patents and materials related to p63 diagnostics in the research and IVD field. In parallel, Biocare and AsymmetRx Medical, Inc. (AsymmetRx) have [...]Read more